Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:565270rdf:typepubmed:Citationlld:pubmed
pubmed-article:565270lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:565270lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:565270lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:565270pubmed:issue1-4lld:pubmed
pubmed-article:565270pubmed:dateCreated1978-6-28lld:pubmed
pubmed-article:565270pubmed:abstractTextTwo strains of murine leukaemic lymphoblasts: L5178Y-R and L5178Y-S differing in the X-ray sensitivity by a factor of ca. 2 and showing X-ray-UV-light cross-sensitivity were exposed to: (a) 104 muCi/ml of HTO for time intervals from 25 to 600 h, (b) 10 muCi/ml of L-[4,5(n)-3H]lysine for 25 to 600 h, and (c) 0.05 muCi/ml of [methyl-3H] thymidine for 4 to 600 h. After completion of the exposure, survival was determined by cloning or by backward extrapolation of growth curves. In the case of HTO and 3H-thymidine exposure time the survival relationship passed through broad minima (75--200 and 50--400 h for (a) and (c), respectively). After longer exposures, higher survivals were observed reaching values close to 1 in the extreme cases. The results of shorter exposures indicate that L5178Y-R and L5178Y-S cells considerably differ in their susceptibilities to the tritiated compounds and that this difference increases with the shift of 3H localization towards DNA.lld:pubmed
pubmed-article:565270pubmed:languageenglld:pubmed
pubmed-article:565270pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:565270pubmed:citationSubsetIMlld:pubmed
pubmed-article:565270pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:565270pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:565270pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:565270pubmed:statusMEDLINElld:pubmed
pubmed-article:565270pubmed:monthJanlld:pubmed
pubmed-article:565270pubmed:issn0011-3964lld:pubmed
pubmed-article:565270pubmed:authorpubmed-author:SzumielIIlld:pubmed
pubmed-article:565270pubmed:authorpubmed-author:BeerJ ZJZlld:pubmed
pubmed-article:565270pubmed:authorpubmed-author:BudzickaEElld:pubmed
pubmed-article:565270pubmed:authorpubmed-author:WalickaMMlld:pubmed
pubmed-article:565270pubmed:issnTypePrintlld:pubmed
pubmed-article:565270pubmed:volume12lld:pubmed
pubmed-article:565270pubmed:ownerNLMlld:pubmed
pubmed-article:565270pubmed:authorsCompleteYlld:pubmed
pubmed-article:565270pubmed:pagination157-67lld:pubmed
pubmed-article:565270pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-A...lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-M...lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-X...lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-E...lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-L...lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-L...lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-L...lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-T...lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-T...lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-C...lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-C...lld:pubmed
pubmed-article:565270pubmed:meshHeadingpubmed-meshheading:565270-R...lld:pubmed
pubmed-article:565270pubmed:year1978lld:pubmed
pubmed-article:565270pubmed:articleTitleSusceptibility of L5178Y-R and L5178Y-S cells to HTO, 3H-lysine and 3H-thymidine exposure.lld:pubmed
pubmed-article:565270pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:565270pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:565270pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed